Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate Toxicity
This treatment has been approved for sale to the public.
Sponsor:
Protherics
Collaborators:
BTG Ltd.
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):
Protherics
ClinicalTrials.gov Identifier:
NCT00481559
First received: May 30, 2007
Last updated: May 1, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This treatment has been approved for sale to the public. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |